Resolutions from extraordinary general meeting in PledPharma AB (publ) held on 11 December 2020
December 11, 2020
The extraordinary general meeting in PledPharma AB (publ) (“PledPharma” or the “Company”) was held today on 11 December 2020, where the general meeting resolved in accordance with submitted proposals. The complete proposals are set out in the notice to the general meeting.
The general meeting resolved among others to adopt a new articles of association so that sections 1 (name), 3 (object of the company’s business), 4 (share capital), 5 (number of shares) and 8 (notification of and the right of participation in shareholders’ meeting) were amended.
Following registration of the new articles of association with the Swedish Companies Registration Office, the Company’s name will change to Egetis Therapeutics AB (publ).